- Home
- NYMT vs XNCR Comparison
NYMT vs XNCR Comparison
Compare NYMT & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYMT
- XNCR
- Stock Information
- Founded
- NYMT 2003
- XNCR 1997
- Country
- NYMT United States
- XNCR United States
- Employees
- NYMT N/A
- XNCR N/A
- Industry
- NYMT Real Estate Investment Trusts
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- NYMT Real Estate
- XNCR Health Care
- Exchange
- NYMT Nasdaq
- XNCR Nasdaq
- Market Cap
- NYMT 615.9M
- XNCR 547.8M
- IPO Year
- NYMT 2004
- XNCR 2013
- Fundamental
- Price
- NYMT $7.24
- XNCR $8.60
- Analyst Decision
- NYMT Strong Buy
- XNCR Buy
- Analyst Count
- NYMT 4
- XNCR 10
- Target Price
- NYMT $7.81
- XNCR $23.33
- AVG Volume (30 Days)
- NYMT 557.4K
- XNCR 700.0K
- Earning Date
- NYMT 10-29-2025
- XNCR 11-05-2025
- Dividend Yield
- NYMT 11.27%
- XNCR N/A
- EPS Growth
- NYMT N/A
- XNCR N/A
- EPS
- NYMT 0.19
- XNCR N/A
- Revenue
- NYMT $205,403,000.00
- XNCR $146,929,000.00
- Revenue This Year
- NYMT $9.04
- XNCR $22.06
- Revenue Next Year
- NYMT $22.80
- XNCR N/A
- P/E Ratio
- NYMT $36.97
- XNCR N/A
- Revenue Growth
- NYMT 23.27
- XNCR N/A
- 52 Week Low
- NYMT $5.02
- XNCR $6.92
- 52 Week High
- NYMT $7.27
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- NYMT 57.43
- XNCR 57.89
- Support Level
- NYMT $6.92
- XNCR $8.25
- Resistance Level
- NYMT $7.49
- XNCR $8.73
- Average True Range (ATR)
- NYMT 0.17
- XNCR 0.38
- MACD
- NYMT 0.00
- XNCR 0.07
- Stochastic Oscillator
- NYMT 56.64
- XNCR 78.76
About NYMT New York Mortgage Trust Inc.
New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets. Geographically operates in USA states California, New York, Florida, New Jersey, Illinois, maximum from California.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.